Pharmaceuticals and Vaccines


Pandemic Influenza: Science, Economics, and Foreign Policy

Session One:
The Science
Arnold Monto, Professor, Epidemiology, University of Michigan
Peter Palese, Professor and Chair, Microbiology, and Professor of Medicine, Infectious Diseases, Mount Sinai School of Medicine
Lone Simonsen, Research Professor and Research Director, Department of Global Health, George Washington University
Presider: Jon Cohen, Correspondent, Science Magazine
8:00 to 8:30 AM Breakfast Reception
8:30 to 9:45 AM Meeting

Session Two:
The Economics
Andrew Yanzhong Huang, Director, Center for Global Health Studies, Seton Hall University
Andrew Jack, Pharmaceutical Correspondent, Financial Times
Michael Osterholm, Director, Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota
Presider: Robert Rubin, Former U.S. Secretary of the Treasury; Co-Chair, Council on Foreign Relations
10:00 to 11:15 AM Meeting

Session Three:
Foreign Policy
Helen Branswell,
Medical Reporter, Canadian Press
John E. Lange, Senior Program Officer for Developing-Country Policy and Advocacy, Global Health Program, Bill and Melinda Gates Foundation
Presider: Laurie Garrett, Senior Fellow for Global Health, Council on Foreign Relations
11:30 AM to 12:45 PM Meeting
12:45 to 1:30 PM Lunch Reception

See more in Global; Pharmaceuticals and Vaccines; Public Health Threats and Pandemics


Open Minds, Open Labs: Breaking Down the Barriers to Innovation and Access to Medicines in the Developing World

Speaker: Andrew Witty
Presider: Vijay V. Vaitheeswaran

This meeting is part of the CEO speaker series. This series provides a forum for leading global CEOs to share their priorities and insights before a high-level audience of CFR members. The series aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership. Members benefit from hearing CEOs' perspectives as well as interacting with them in an informal setting; in turn, CEOs have the opportunity to highlight the work of their organization and strengthen their relationship with CFR.

See more in Global; Diseases, Infectious; Pharmaceuticals and Vaccines